- Home
- SPHR vs KNSA Comparison
SPHR vs KNSA Comparison
Compare SPHR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHR
- KNSA
- Stock Information
- Founded
- SPHR 2020
- KNSA 2015
- Country
- SPHR United States
- KNSA United Kingdom
- Employees
- SPHR N/A
- KNSA N/A
- Industry
- SPHR Services-Misc. Amusement & Recreation
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- SPHR Consumer Discretionary
- KNSA Health Care
- Exchange
- SPHR Nasdaq
- KNSA Nasdaq
- Market Cap
- SPHR 1.4B
- KNSA 1.3B
- IPO Year
- SPHR N/A
- KNSA 2018
- Fundamental
- Price
- SPHR $46.55
- KNSA $19.47
- Analyst Decision
- SPHR Buy
- KNSA Strong Buy
- Analyst Count
- SPHR 9
- KNSA 5
- Target Price
- SPHR $49.33
- KNSA $36.60
- AVG Volume (30 Days)
- SPHR 653.9K
- KNSA 557.8K
- Earning Date
- SPHR 02-11-2025
- KNSA 02-26-2025
- Dividend Yield
- SPHR N/A
- KNSA N/A
- EPS Growth
- SPHR N/A
- KNSA N/A
- EPS
- SPHR N/A
- KNSA N/A
- Revenue
- SPHR $1,136,795,000.00
- KNSA $384,098,000.00
- Revenue This Year
- SPHR $10.14
- KNSA $60.10
- Revenue Next Year
- SPHR $9.11
- KNSA $36.31
- P/E Ratio
- SPHR N/A
- KNSA N/A
- Revenue Growth
- SPHR 99.89
- KNSA 54.41
- 52 Week Low
- SPHR $32.10
- KNSA $16.56
- 52 Week High
- SPHR $51.83
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- SPHR 62.70
- KNSA 42.61
- Support Level
- SPHR $44.54
- KNSA $18.47
- Resistance Level
- SPHR $47.79
- KNSA $20.90
- Average True Range (ATR)
- SPHR 1.58
- KNSA 0.72
- MACD
- SPHR 0.17
- KNSA -0.01
- Stochastic Oscillator
- SPHR 64.09
- KNSA 24.71
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.